Clinical Trial Update: ACT-128800 in Patients With Moderate to Severe Chronic Plaque Psoriasis [Phase 2]

View source ↗

Summary

A Phase 2 trial of ACT-128800 in patients with moderate to severe chronic plaque psoriasis has completed. The document notes the study status as COMPLETED and i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• ACT-128800

Snippet

Sponsor: Actelion | Conditions: Psoriasis | Phase 2 | Status: COMPLETED